CS-8958

DRUG2 trials

Sponsors

Daiichi Sankyo Co., Ltd., Biota Scientific Management Pty Ltd

Conditions

InfluenzaInfluenza, Human

Phase 1

Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958

CompletedNCT00995826

Biota Scientific Management Pty LtdInfluenza

Start: 2009-04-30End: 2009-11-30Updated: 2018-05-30

Phase 3

A Multinational Phase III Study of CS-8958 (MARVEL)

CompletedNCT00803595

Daiichi Sankyo Co., Ltd.Influenza, Human

Start: 2008-11-30End: 2009-06-30Updated: 2019-01-09

Related Papers

Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

2010-10-11149 citations